CognitMarket market news, portfolio research, and investor insights

Your market command center

Research the market. Understand your portfolio. Act with confidence.

Turn market-moving news into a focused daily view of the companies, portfolios, and ideas you care about.

Login
Create my free account
Free to start · No card required

Top Stories

The developments most likely to shape today’s market conversation.
‘Parasite’ backer and other South Korean media, gaming and travel stocks rally on China trade deal
Sector News

‘Parasite’ backer and other South Korean media, gaming and travel stocks rally on China trade deal

CNBC.COM

South Korean entertainment, gaming and travel stocks surged Thursday as Seoul and Beijing largely concluded a trade deal, allowing Korean companies greater access to China’s vast consumer market.

South Korean entertainment industry has faced Chinese curbs for nearly a decade, and a deal stands to open up new revenue streams for Seoul’s media, gaming and tourism industries.

Drama producer Studio Dragon — who created the drama Crash Landing on You — soared 29.96%, while media giant CJ ENM, which backed the Oscar-winning film “Parasite,” jumped 26% early Thursday.

Travel agency Hana Tour rose 18%, while film distributor Showbox gained 9%. South Korea’s gaming stocks Krafton and Shift Up advanced 2.69% and 6.57%, respectively.

Shift Up had created the action role-playing game Stellar Blade, the first South Korean game funded and published in an official partnership with PlayStation, while Krafton is the developer of battle royale game PUBG: Battlegrounds.

South Korea’s Ministry of Tra

BillionToOne shares slide in pre-market trading following short-seller report
Company News

BillionToOne shares slide in pre-market trading following short-seller report

STREETINSIDER.COM

Investing.com -- Shares of molecular diagnostics company BillionToOne, Inc. (NASDAQ: BLLN) fell 6% in pre-market trading Wednesday after short-seller Fuzzy Panda Research published a critical report alleging improper billing practices, undisclosed regulatory scrutiny and potential weaknesses in the company’s clinical claims.

Fuzzy Panda disclosed that it holds a short position in BillionToOne and stands to profit if the stock declines. The report draws on state Freedom of Information Act (FOIA) requests, interviews with anonymous former employees and discussions with physicians. BillionToOne has not publicly responded to the allegations, which have not been established through regulatory findings or court proceedings.

A central focus of the report is Tennessee Medicaid documentation. According to Fuzzy Panda’s interpretation of records obtained from the state, the Office of Program Integrity opened an inquiry in 2024 following 11 tips and referred the matter to the Tennessee Bureau o

Medical costs are crushing insurers—and lifting LivaNova stock
Company News

Medical costs are crushing insurers—and lifting LivaNova stock

INVESTING.COM

Investing.com and Yahoo Finance LLC may earn commission or revenue on some items through the links below.

Investing.com — Managed care health insurers have spent the year getting hammered by surging medical cost ratios and elevated procedure utilization, leading many investors to avoid healthcare stocks altogether. Device makers have not escaped either: LivaNova’s InvestingPro peer group, which includes Abbott Laboratories (NYSE:ABT), Boston Scientific (NYSE:BSX), and Medtronic (NYSE:MDT), has posted a 19.1% one-year total return loss. Yet LivaNova PLC (NASDAQ:LIVN)—the maker of heart-lung machines and epilepsy implants—has returned 65.0% over the same period, including a 15.64% surge since November 1 to $91.32.

LivaNova is winning from the same trend that is hurting insurers: the rise in surgical procedures squeezing insurer margins is driving steady, high-margin device demand for its cardiopulmonary and neuromodulation platforms. Even after the rally, the shares trade at 20.6 times

Barclays upgrades Sonova as Phonak EON drives hearing-aid market share gains
Analyst & Opinion

Barclays upgrades Sonova as Phonak EON drives hearing-aid market share gains

STREETINSIDER.COM

Investing.com -- Barclays has upgraded Sonova to "overweight" from "underweight", identifying the Swiss hearing-aid manufacturer as its preferred investment in the sector as its latest survey of U.S. audiologists points to improving demand for its newest products.

The brokerage raised its price target to CHF330 from CHF220, arguing that Sonova's Phonak EON hearing aids could help the company gain market share at the expense of competitors, particularly Demant. Barclays expects Sonova's earnings growth to accelerate, with further potential upside as its product portfolio expands.

The bank's survey of 148 independent US audiologists found that Phonak is expected to gain about 197 basis points of market share over the next six months. Demant's Oticon brand is projected to lose 140 basis points, while GN Store Nord's ReSound is expected to shed 21 basis points.

Phonak EON received the strongest product differentiation assessment, with 78% of respondents describing it as moderately or si

SNL’s Viral ‘Sister’ Sketch Nails the $1 Trillion Reality of Unpaid Family Caregiving
Sector News

SNL’s Viral ‘Sister’ Sketch Nails the $1 Trillion Reality of Unpaid Family Caregiving

INVESTOPEDIA.COM

Get personalized, AI-powered answers built on 27+ years of trusted expertise.

A “Saturday Night Live” fake ad for a free caregiver called Sister is going viral this week because millions of families already use this readily available “product” meant to save a fortune in care costs.

The pre-taped sketch, which first aired Nov. 14 and has drawn millions of views on YouTube, stars host John Mulaney as a son facing the question many families with aging parents eventually must answer: who’s going to take care of their parent?1 “I didn’t want to put him in a nursing home, but a private health aide could cost thousands a week,” Mulaney’s character says. “I didn’t know where to turn.”

The son’s answer is Sister, played by Jane Wickline, and the fake ad spells out just what “free” care is costing her. Text Sister, the voiceover promises, and “she will quit her job, break her lease, and move halfway across the country to take care of him.”

The fake ad is right about the price. Home care cost

1 / 6

For You

Personalize this briefing around the investments you care about.

Follow the market through your own lens.

Create a free account to bring watchlist updates, portfolios, and Autopilot status into this briefing.

Trending now

Top portfolios

From the Community

Recent questions, research, and investing ideas from members.

Deutsche Bank initiates coverage on the U.S. tower sector with a neutral outlook but names American Tower (AMT) its top pick, assigning a Buy rating and $222 price target .

Key points:

  • AMT Strengths: Best-in-class U.S. portfolio driving industry-leading organic tenant billings growth (4.3% vs. peers' 3.4-3.5% for 2027-2029), diversified international business, and colocation data center platform benefiting from AI and digital transformation .
  • Sector Headwinds: Near-term U.S. wireless network investment trough expected through 2027 .
  • Long-Term Drivers: Healthy demand, high barriers to entry, long-term contracts, and future catalysts like 6G and data-intensive apps expected mid-to-late 2028 .
Deutsche Bank Names Top North America Telecom Services Stock

Deutsche Bank Names Top North America Telecom Services Stock

STREETINSIDER.COMNov 18, 3:40 PM UTC
1

Shares of molecular diagnostics company BillionToOne (BLLN) slid 6% in pre-market trading after Fuzzy Panda Research published a critical short-seller report. The report alleges improper billing practices, undisclosed regulatory scrutiny, and weaknesses in clinical claims .

Key allegations include:

  • Tennessee Medicaid inquiry in 2024 following 11 tips, referred to Medicaid Fraud Control Division.
  • Alleged use of 'unlisted' CPT codes paying ~10x standard rates.
  • Questionable billing for once-in-a-lifetime genetic carrier screening alongside 88% of NIPTs in Michigan Medicaid data.

Fuzzy Panda holds a short position. BillionToOne has not yet responded to the allegations .

BillionToOne shares slide in pre-market trading following short-seller report

BillionToOne shares slide in pre-market trading following short-seller report

STREETINSIDER.COMNov 18, 2:19 PM UTC
1

Nvidia's Q4 revenue forecast of $130B (±3%), exceeding analyst estimates of $125.25B, has eased concerns about the chip bellwether and boosted AI-linked stocks . Shares of NVDA rose 2.6% in premarket trading, with rival chipmakers AMD, Broadcom, Micron, and Marvell also gaining 1.5-2% .

This positive outlook comes after recent investor uncertainty following former CEO Jensen Huang's exit and a broader 'AI trade' sell-off . Attention now shifts to Anthropic's IPO pricing, which could value the Claude chatbot creator at up to $1.4 trillion, serving as a key test for Wall Street's appetite for frontier AI model developers .

Nasdaq poised for higher open as Nvidia forecast eases AI concerns

Nasdaq poised for higher open as Nvidia forecast eases AI concerns

STREETINSIDER.COMNov 18, 10:28 AM UTC
Barclays spots cracks in AI trade, turns bullish on U.S. Quality

Barclays spots cracks in AI trade, turns bullish on U.S. Quality

STREETINSIDER.COMNov 18, 2:20 PM UTC
Bitcoin stays below $65k as rate jitters persist; Fed minutes awaited

Bitcoin stays below $65k as rate jitters persist; Fed minutes awaited

STREETINSIDER.COMNov 18, 12:16 PM UTC
1 / 3
1

US Treasury yields hold steady as markets await today's FOMC minutes for insights into the Fed's rate path. Stronger-than-expected October retail sales (+0.6% ex-gas/auto) are bolstering expectations for further tightening. Traders now price in a 95% chance of a quarter-point rate hike .

Treasury yields hold steady as investors look ahead to Fed minutes

Treasury yields hold steady as investors look ahead to Fed minutes

CNBC.COMNov 18, 9:32 AM UTC
1

Credo Technology (CRDO) and Marvell Technology (MRVL) have settled their intellectual property dispute concerning Active Electrical Cable (AEC) technology, crucial for AI data infrastructure. The agreement resolves patent challenges initiated by Marvell against Credo. This removes a legal overhang for both chipmakers competing in the rapidly expanding AI data center market. CRDO rose ~2% and MRVL gained 0.5% in after-hours trading following the news .

Credo, Marvell settle intellectual property battle over data center cable tech

Credo, Marvell settle intellectual property battle over data center cable tech

INVESTING.COMNov 17, 10:06 PM UTC
1

Walmart (WMT) is set to report Q3 earnings Thursday morning. Analysts anticipate $187.3B in revenue and $5.02B in net income .

Key points:

  • Stock is up 15% YTD, outperforming the S&P 500 .
  • Options market data suggests a potential 6% move in either direction post-earnings .
  • Midyear report included a less optimistic Q3 outlook, setting a cautious tone .
  • Investors will also monitor commentary for insights into U.S. consumer health .
Here’s How Much Traders Expect Walmart Stock to Move After Earnings Thursday

Here’s How Much Traders Expect Walmart Stock to Move After Earnings Thursday

INVESTOPEDIA.COMNov 17, 7:18 PM UTC
6

Mizuho has launched coverage on nine asset managers, assigning 'Outperform' ratings to seven, including major players like Apollo Global Management (APO), Ares Management (ARES), and Blackstone (BX) .

Key analyst calls:

  • Apollo (APO): $145 target, market undervalues Athene's earnings support; 26% EPS growth seen in 2027.
  • Ares (ARES): $159 target, current private credit dislocation seen as a buying opportunity.
  • Blackstone (BX): $139 target, fee growth expected to pick up in 2027.

KKR (KKR), Blue Owl Capital (OWL), BlackRock (BLK), and Invesco (IVZ) also received 'Outperform' ratings. TPG (TPG) and Franklin Templeton (BEN) were started at 'Neutral' .

Mizuho starts coverage of asset managers, backs Apollo, Ares and Blackstone

Mizuho starts coverage of asset managers, backs Apollo, Ares and Blackstone

STREETINSIDER.COMNov 17, 4:18 PM UTC
7

Bernstein has cut PepsiCo (PEP) to Underperform from Market-Perform, trimming its price target to $128 from $131. The downgrade is driven by anticipated underperformance in its North American food and beverage businesses.

Key points:

  • North America Pressure: Forecasts volume declines in North American food due to lapping price cuts and falling chip consumption, alongside market share loss to value/premium brands .
  • Margin Squeeze: Limited pricing power, persistent inflation, and rising marketing spend are expected to pressure margins .
  • EPS Forecast: Bernstein projects EPS of $8.51 for the next 12 months, below the $8.91 consensus, citing significant investment needed to revive core businesses .
Bernstein cuts PepsiCo to Underperform on North America pressure

Bernstein cuts PepsiCo to Underperform on North America pressure

STREETINSIDER.COMNov 17, 2:28 PM UTC
4

St. Louis Fed President Alberto Musalem stated the central bank may need as many as four more rate hikes by Spring 2027 to achieve its 2% inflation target. He believes the real policy rate needs to be 2%-2.5%, about a full point above current levels .

Key points:

  • Musalem suggests hikes at upcoming Fed meetings in December, January, March, and April.
  • He views current policy as not significantly restricting economic activity.
  • While not a voting FOMC member until 2028, his views contribute to the 'dot plot' .

This hawkish outlook contrasts with recent market expectations for a pause or cuts, potentially impacting rate-sensitive sectors.

St. Louis Fed’s Musalem says four more rate hikes may be needed in coming months

St. Louis Fed’s Musalem says four more rate hikes may be needed in coming months

CNBC.COMNov 17, 1:40 PM UTC
4

Nvidia (NVDA) significantly reshuffled its Q3 portfolio, cutting stakes in several tech companies while increasing its position in SpaceX. This move led to immediate market reactions for affected stocks:

  • Nokia (NOK): Shares fell over 4% after Nvidia reduced its stake by 56% .
  • Intel (INTC): Shares dropped over 3% premarket as Nvidia trimmed its holding by 25% .
  • Synopsys (SNPS): Nvidia also cut its Synopsys position by nearly 10% .

Conversely, Nvidia increased its SpaceX holding, making it the largest disclosed equity investment in its portfolio, valued at $19.7 billion . This portfolio adjustment signals a shift in Nvidia's investment strategy.

Nokia stock tumbles after Nvidia cuts stake by more than half

Nokia stock tumbles after Nvidia cuts stake by more than half

INVESTING.COMNov 17, 9:03 AM UTC
Intel falls premarket as Nvidia cuts stake, SpaceX becomes top holding

Intel falls premarket as Nvidia cuts stake, SpaceX becomes top holding

INVESTING.COMNov 17, 9:56 AM UTC
1 / 2
3